.tb-grid,.tb-grid>.block-editor-inner-blocks>.block-editor-block-list__layout{display:grid;grid-row-gap:25px;grid-column-gap:25px}.tb-grid-item{background:#d38a03;padding:30px}.tb-grid-column{flex-wrap:wrap}.tb-grid-column>*{width:100%}.tb-grid-column.tb-grid-align-top{width:100%;display:flex;align-content:flex-start}.tb-grid-column.tb-grid-align-center{width:100%;display:flex;align-content:center}.tb-grid-column.tb-grid-align-bottom{width:100%;display:flex;align-content:flex-end} .wpv-view-output[data-toolset-views-view-editor="c7d7eaee214bfc4b89a7a8f9156bcb42"] > .tb-grid-column:nth-of-type(3n + 1) { grid-column: 1 } .wpv-view-output[data-toolset-views-view-editor="c7d7eaee214bfc4b89a7a8f9156bcb42"] > .tb-grid-column:nth-of-type(3n + 2) { grid-column: 2 } .wpv-view-output[data-toolset-views-view-editor="c7d7eaee214bfc4b89a7a8f9156bcb42"] > .tb-grid-column:nth-of-type(3n + 3) { grid-column: 3 } .wpv-view-output[data-toolset-views-view-editor="c7d7eaee214bfc4b89a7a8f9156bcb42"] .js-wpv-loop-wrapper > .tb-grid { grid-template-columns: minmax(0, 0.3333fr) minmax(0, 0.3333fr) minmax(0, 0.3333fr);grid-auto-flow: row } .wpv-view-output[data-toolset-views-view-editor="c7d7eaee214bfc4b89a7a8f9156bcb42"] .tb-masonry { grid-template-columns: minmax(0, 1fr) minmax(0, 1fr) minmax(0, 1fr);grid-column-gap: 10px; } .wpv-view-output[data-toolset-views-view-editor="c7d7eaee214bfc4b89a7a8f9156bcb42"] .tb-masonry .tb-brick__content { padding: 0 0 10px 0; } .wpv-pagination-previous-next-buttons[data-toolset-views-view-pagination-block="b9090cc0f78d6ede3c1e5943bedbe4eb"] { text-align: left;text-align: left; } .tb-container .tb-container-inner{width:100%;margin:0 auto} .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="9a5ee001ed05d4b1aa49212a1db27426"] { padding: 0px;border: 1px solid rgba( 218, 218, 218, 1 ); } .tb-container .tb-container-inner{width:100%;margin:0 auto} .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="990c9c2cfdf30509af9fb91cc8dfd7d9"] { background: rgba( 250, 246, 246, 1 );padding: 15px 15px 5px 15px;margin-top: 0px;border: 0px solid rgba( 0, 0, 0, 1 ); } .tb-button{color:#f1f1f1}.tb-button--left{text-align:left}.tb-button--center{text-align:center}.tb-button--right{text-align:right}.tb-button__link{color:inherit;cursor:pointer;display:inline-block;line-height:100%;text-decoration:none !important;text-align:center;transition:all 0.3s ease}.tb-button__link:hover,.tb-button__link:focus,.tb-button__link:visited{color:inherit}.tb-button__link:hover .tb-button__content,.tb-button__link:focus .tb-button__content,.tb-button__link:visited .tb-button__content{font-family:inherit;font-style:inherit;font-weight:inherit;letter-spacing:inherit;text-decoration:inherit;text-shadow:inherit;text-transform:inherit}.tb-button__content{vertical-align:middle;transition:all 0.3s ease}.tb-button__icon{transition:all 0.3s ease;display:inline-block;vertical-align:middle;font-style:normal !important}.tb-button__icon::before{content:attr(data-font-code);font-weight:normal !important}.tb-button__link{background-color:#444;border-radius:0.3em;font-size:1.3em;margin-bottom:0.76em;padding:0.55em 1.5em 0.55em} .tb-button[data-toolset-blocks-button="d2e2b11f87f20192f81acf521a2702ac"] .tb-button__link { background-color: rgba( 155, 81, 224, 1 );font-size: 12px;text-transform: capitalize; } .tb-button[data-toolset-blocks-button="d2e2b11f87f20192f81acf521a2702ac"] .tb-button__icon { font-family: dashicons; } .tb-fields-and-text[data-toolset-blocks-fields-and-text="f5edf74ba0d6c65cc57b11e8dbedbdab"] { padding-bottom: 10px; }  .tb-image{position:relative;transition:transform 0.25s ease}.wp-block-image .tb-image.aligncenter{margin-left:auto;margin-right:auto}.tb-image img{max-width:100%;height:auto;width:auto;transition:transform 0.25s ease}.tb-image .tb-image-caption-fit-to-image{display:table}.tb-image .tb-image-caption-fit-to-image .tb-image-caption{display:table-caption;caption-side:bottom} .wp-block-image.tb-image[data-toolset-blocks-image="0fdd4389f075a4ed0af48d745708746c"] { max-width: 100%; } .wp-block-image.tb-image[data-toolset-blocks-image="0fdd4389f075a4ed0af48d745708746c"] img { background-color: rgba( 250, 246, 246, 1 );border: 0px solid rgba( 0, 0, 0, 1 ); } h1.tb-heading[data-toolset-blocks-heading="f20b0d65f0e712fa9cc243154abfa763"]  { color: rgba( 255, 255, 255, 1 );background-color: rgba( 207, 46, 46, 1 );border-radius: 0;padding: 10px; }  h1.tb-heading[data-toolset-blocks-heading="f20b0d65f0e712fa9cc243154abfa763"] a  { color: rgba( 255, 255, 255, 1 ); } @media only screen and (max-width: 781px) { .tb-grid,.tb-grid>.block-editor-inner-blocks>.block-editor-block-list__layout{display:grid;grid-row-gap:25px;grid-column-gap:25px}.tb-grid-item{background:#d38a03;padding:30px}.tb-grid-column{flex-wrap:wrap}.tb-grid-column>*{width:100%}.tb-grid-column.tb-grid-align-top{width:100%;display:flex;align-content:flex-start}.tb-grid-column.tb-grid-align-center{width:100%;display:flex;align-content:center}.tb-grid-column.tb-grid-align-bottom{width:100%;display:flex;align-content:flex-end} .wpv-view-output[data-toolset-views-view-editor="c7d7eaee214bfc4b89a7a8f9156bcb42"] > .tb-grid-column:nth-of-type(3n + 1) { grid-column: 1 } .wpv-view-output[data-toolset-views-view-editor="c7d7eaee214bfc4b89a7a8f9156bcb42"] > .tb-grid-column:nth-of-type(3n + 2) { grid-column: 2 } .wpv-view-output[data-toolset-views-view-editor="c7d7eaee214bfc4b89a7a8f9156bcb42"] > .tb-grid-column:nth-of-type(3n + 3) { grid-column: 3 } .wpv-view-output[data-toolset-views-view-editor="c7d7eaee214bfc4b89a7a8f9156bcb42"] .js-wpv-loop-wrapper > .tb-grid { grid-template-columns: minmax(0, 0.3333fr) minmax(0, 0.3333fr) minmax(0, 0.3333fr);grid-auto-flow: row } .wpv-view-output[data-toolset-views-view-editor="c7d7eaee214bfc4b89a7a8f9156bcb42"] .tb-masonry { grid-template-columns: minmax(0, 1fr) minmax(0, 1fr);grid-column-gap: 10px; } .wpv-view-output[data-toolset-views-view-editor="c7d7eaee214bfc4b89a7a8f9156bcb42"] .tb-masonry .tb-brick__content { padding: 0 0 10px 0; } .tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-button{color:#f1f1f1}.tb-button--left{text-align:left}.tb-button--center{text-align:center}.tb-button--right{text-align:right}.tb-button__link{color:inherit;cursor:pointer;display:inline-block;line-height:100%;text-decoration:none !important;text-align:center;transition:all 0.3s ease}.tb-button__link:hover,.tb-button__link:focus,.tb-button__link:visited{color:inherit}.tb-button__link:hover .tb-button__content,.tb-button__link:focus .tb-button__content,.tb-button__link:visited .tb-button__content{font-family:inherit;font-style:inherit;font-weight:inherit;letter-spacing:inherit;text-decoration:inherit;text-shadow:inherit;text-transform:inherit}.tb-button__content{vertical-align:middle;transition:all 0.3s ease}.tb-button__icon{transition:all 0.3s ease;display:inline-block;vertical-align:middle;font-style:normal !important}.tb-button__icon::before{content:attr(data-font-code);font-weight:normal !important}.tb-button__link{background-color:#444;border-radius:0.3em;font-size:1.3em;margin-bottom:0.76em;padding:0.55em 1.5em 0.55em} .tb-image{position:relative;transition:transform 0.25s ease}.wp-block-image .tb-image.aligncenter{margin-left:auto;margin-right:auto}.tb-image img{max-width:100%;height:auto;width:auto;transition:transform 0.25s ease}.tb-image .tb-image-caption-fit-to-image{display:table}.tb-image .tb-image-caption-fit-to-image .tb-image-caption{display:table-caption;caption-side:bottom}  } @media only screen and (max-width: 599px) { .tb-grid,.tb-grid>.block-editor-inner-blocks>.block-editor-block-list__layout{display:grid;grid-row-gap:25px;grid-column-gap:25px}.tb-grid-item{background:#d38a03;padding:30px}.tb-grid-column{flex-wrap:wrap}.tb-grid-column>*{width:100%}.tb-grid-column.tb-grid-align-top{width:100%;display:flex;align-content:flex-start}.tb-grid-column.tb-grid-align-center{width:100%;display:flex;align-content:center}.tb-grid-column.tb-grid-align-bottom{width:100%;display:flex;align-content:flex-end} .wpv-view-output[data-toolset-views-view-editor="c7d7eaee214bfc4b89a7a8f9156bcb42"]  > .tb-grid-column:nth-of-type(1n+1) { grid-column: 1 } .wpv-view-output[data-toolset-views-view-editor="c7d7eaee214bfc4b89a7a8f9156bcb42"] .js-wpv-loop-wrapper > .tb-grid { grid-template-columns: minmax(0, 1fr);grid-auto-flow: row } .wpv-view-output[data-toolset-views-view-editor="c7d7eaee214bfc4b89a7a8f9156bcb42"] .tb-masonry { grid-template-columns: minmax(0, 1fr);grid-column-gap: 10px; } .wpv-view-output[data-toolset-views-view-editor="c7d7eaee214bfc4b89a7a8f9156bcb42"] .tb-masonry .tb-brick__content { padding: 0 0 10px 0; } .tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-button{color:#f1f1f1}.tb-button--left{text-align:left}.tb-button--center{text-align:center}.tb-button--right{text-align:right}.tb-button__link{color:inherit;cursor:pointer;display:inline-block;line-height:100%;text-decoration:none !important;text-align:center;transition:all 0.3s ease}.tb-button__link:hover,.tb-button__link:focus,.tb-button__link:visited{color:inherit}.tb-button__link:hover .tb-button__content,.tb-button__link:focus .tb-button__content,.tb-button__link:visited .tb-button__content{font-family:inherit;font-style:inherit;font-weight:inherit;letter-spacing:inherit;text-decoration:inherit;text-shadow:inherit;text-transform:inherit}.tb-button__content{vertical-align:middle;transition:all 0.3s ease}.tb-button__icon{transition:all 0.3s ease;display:inline-block;vertical-align:middle;font-style:normal !important}.tb-button__icon::before{content:attr(data-font-code);font-weight:normal !important}.tb-button__link{background-color:#444;border-radius:0.3em;font-size:1.3em;margin-bottom:0.76em;padding:0.55em 1.5em 0.55em} .tb-image{position:relative;transition:transform 0.25s ease}.wp-block-image .tb-image.aligncenter{margin-left:auto;margin-right:auto}.tb-image img{max-width:100%;height:auto;width:auto;transition:transform 0.25s ease}.tb-image .tb-image-caption-fit-to-image{display:table}.tb-image .tb-image-caption-fit-to-image .tb-image-caption{display:table-caption;caption-side:bottom}  } 

Latest Appointments

CN Bio introduces Dr Tomasz Kostrzewski as new chief scientific officer

August 31, 2023 Business Services CN Bio, CSO, Dr Tomasz Kostrzewski

On 30August 2023, CN Bio announced the appointment of Dr Tomasz Kostrzewski as chief scientific officer (CSO) – a new …

Appointment

Destiny Pharma appoints new CEO Chris Tovey

August 21, 2023 Business Services CEO, Chris Tovey, Destiny Pharma

Destiny Pharma has announced the appointment of Chris Tovey, who will be replacing Dr Debra Barker as chief executive officer; …

Appointment

Foghorn Therapeutics appoints Alfonso Quintás-Cardama as new chief medical officer

August 18, 2023 Business Services Alfonso Quintas-Cardama, Foghorn Therapeutics, chief medical officer

The biotechnology company Foghorn Therapeutics has announced the addition of the new chief medical officer, Alfonso Quintás-Cardama, who will be …

Appointment

Dr Michael Lutz appointed as new chief executive officer of iotaSciences

August 18, 2023 Business Services Dr Michael Lutz, chief executive officer, iotasciences

The pharmaceutical discovery company iotaSciences has announced that it has appointed Dr Michael Lutz as its new chief executive officer. …

Appointment

Roger Dmochowski appointed as Versameb’s chief medical officer

July 5, 2023 Business Services Roger Dmochowski, Versameb, appointment, chief medical officer

Versameb AB has announced the appointment of Professor Roger Dmochowski as chief medical officer. Dmochowski is a renowned researcher and …

Appointment

Cytovation appoints Olav Hellebø to board of directors

July 5, 2023 Business Services Cytovation, Olav Hellebø, appointment, board of directors

Cytovation ASA, a clinical stage immune-oncology company with a focus on targeted tumour membrane immunotherapies, has announced that it has …

Appointment

Josef Penninger appointed as new scientific director of Helmholtz Centre for Infection Research

July 3, 2023 Business Services Helmholtz Centre for Infection Research, Josef Penninger, appointment, scientific director

The Helmholtz Centre for Infection Research (HZI), Germany, has appointed Professor Josef Penninger as scientific director. Penninger has previously worked …

Appointment

Kevin Hawkins appointed as Reacta’s head of regulatory affairs

July 3, 2023 Business Services Kevin Hawkins, Reacta, appointment, head of regulatory affairs

Reacta Healthcare, an early-stage food allergy diagnostic company, has announced the appointment of Kevin Hawkins as head of regulatory affairs. …

Appointment

Immodulon appoints Josefine Roemmler-Zehrer as chief medical officer

June 20, 2023 Immodulon, Josefine Roemmler-Zehrer, appointment, chief medical officer

Cancer immunotherapy company Immodulon has announced that it has appointed Josefine Roemmler-Zehrer as chief medical officer, bringing with her vast …

Appointment